Letters To The Editor

Vaginal approach is the most cost-effective route

Anupama Kotha, MD, MS; Joseph S. Sanfilippo, MD, MBA


 

References

Vaginal approach is the most cost-effective route

I applaud Drs. Kotha and Sanfilippo for addressing the “elephant in the room.” At the hospitals where I work, surgeons pay little or no attention to the cost of the disposables and operating room time used for their laparoscopic procedures. I believe the authors were remiss, though, to not at least mention the most minimally invasive approach to hysterectomy—the vaginal approach—which is by far the most cost-effective and safest route.

Thomas Powers, MD

Arcadia, California

Drs. Kotha and Sanfilippo respond

We appreciate Dr. Powers’ comments regarding our article on cost-conscious choices for minimally invasive gynecologic surgery. Indeed, he provides an important point. As the article’s overall focus, however, was on minimally invasive gynecologic surgery, we did not include a comparison with either abdominal or vaginal hysterectomy. Of interest, Warren and colleagues conducted a retrospective analysis of claims data in which expenditures for minimally invasive procedures (MIP) were compared with those of vaginal hysterectomy.1 For 15,404 patients who underwent surgery, costs were compared between MIP and abdominal as well as vaginal hysterectomy. Costs were as follows:

  • abdominal hysterectomy, $12,086
  • MIP, $10,868
  • vaginal hysterectomy, $9,544.

Vaginal hysterectomy cost was statistically significantly less (P<.05) compared with other methods. The authors concluded that the laparoscopic approach should be considered when the option of an abdominal versus laparoscopic procedure is entertained. For the gynecologic surgeon considering a laparoscopic approach, the information we provided in our article merits strong consideration.

Recommended Reading

Final ‘Vision’ report addresses MOC woes
MDedge ObGyn
Physician PAC dollars support candidates against gun regulation
MDedge ObGyn
Talk about déjà vu: Senators set to re-enact drug price hearing of 60 years ago
MDedge ObGyn
What does 'Medicare for all' mean?
MDedge ObGyn
Big pharma says it can’t drop drug list prices alone
MDedge ObGyn
Malpractice suits are less frequent – but more costly
MDedge ObGyn
Your 15-year-old patient requests an IUD without parental knowledge
MDedge ObGyn
Drug pricing does not inspire Americans’ trust
MDedge ObGyn
Groups of physicians produce more accurate diagnoses than individuals
MDedge ObGyn
Scott Gottlieb to step down as FDA commissioner
MDedge ObGyn